Tower Research Capital LLC (Trc) Lexaria Bioscience Corp. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,370 shares of LEXX stock, worth $10,177. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,370
Previous 2,702
24.72%
Holding current value
$10,177
Previous $9,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LEXX
# of Institutions
29Shares Held
2.06MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.02MShares$3.08 Million0.04% of portfolio
-
Invenomic Capital Management LP Boston, MA514KShares$1.55 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA115KShares$346,6440.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA93.6KShares$282,6290.0% of portfolio
-
Gen Trust, LLC60KShares$181,2000.01% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $18M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...